标题
Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review
作者
关键词
Rosiglitazone, Liraglutide, Insulin Glargine, Exenatide, Sitagliptin
出版物
PHARMACOECONOMICS
Volume 32, Issue 11, Pages 1079-1091
出版商
Springer Nature
发表日期
2014-07-22
DOI
10.1007/s40273-014-0192-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- AACE Comprehensive Diabetes Management Algorithm 2013
- (2015) Alan Garber et al. Endocrine Practice
- Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
- (2014) Mitch DeKoven et al. ADVANCES IN THERAPY
- The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
- (2013) Sarah Thayer et al. ADVANCES IN THERAPY
- Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
- (2013) Carl V. Asche et al. PHARMACOECONOMICS
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin
- (2013) Pedro Mezquita Raya et al. Diabetes Therapy
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CHINA
- (2012) Lan Gao et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- The Past 200 Years in Diabetes
- (2012) Kenneth S. Polonsky NEW ENGLAND JOURNAL OF MEDICINE
- Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis
- (2012) Elise M. Pelletier et al. JOURNAL OF MEDICAL ECONOMICS
- Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
- (2011) William J. Valentine et al. CLINICAL THERAPEUTICS
- Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US
- (2011) W.C. Lee et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
- (2011) M. J. Davies et al. DIABETIC MEDICINE
- Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States
- (2010) Won Chan Lee et al. CLINICAL THERAPEUTICS
- Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl
- (2010) W. Yang et al. DIABETES OBESITY & METABOLISM
- Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach
- (2010) David Cobden Patient Preference and Adherence
- Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
- (2009) Sean D Sullivan et al. Cardiovascular Diabetology
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
- (2009) Sean D Sullivan et al. PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search